CLBEnergy · Oil & Gas Equipment & ServicesCLB Stock Forecast: Core Laboratories, Inc. Price Predictions for 2026-2027
The 3 Wall Street analysts covering Core Laboratories, Inc. hold a median 12-month price target of $13 — +38.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 44 of 100 as at 22 Oct 2026 — in the lower half.
CLB stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Core Laboratories, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (93): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (19): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
CLB stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on CLB, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +38.3% from it.
Of the 20 most recent actions, 6 moved their price target up and 8 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 16 July 2025 | Stifel | Maintains | Hold | $13 → $12 |
| 13 May 2025 | Citigroup | Maintains | Neutral | — |
| 15 Apr 2025 | Stifel | Maintains | Hold | — |
| 12 Mar 2025 | Citigroup | Upgrade | Neutral | — |
| 20 Feb 2025 | Citigroup | Maintains | Sell | — |
| 31 Oct 2024 | Citigroup | Maintains | Sell | — |
| 26 July 2024 | Stifel | Maintains | Hold | $18 → $22 |
| 15 July 2024 | B of A Securities | Maintains | Underperform | $16 → $15 |
| 15 July 2024 | Piper Sandler | Maintains | Neutral | $18 → $17 |
| 26 Apr 2024 | Stifel | Maintains | Hold | $17 → $18 |
| 15 Apr 2024 | B of A Securities | Maintains | Underperform | $17 → $16 |
| 5 Feb 2024 | Stifel | Maintains | Hold | $21 → $17 |
| 29 Jan 2024 | Stifel | Maintains | Hold | $23 → $21 |
| 18 Sept 2023 | Citigroup | Maintains | Sell | $21 → $20 |
| 31 July 2023 | Piper Sandler | Maintains | Neutral | $19 → $21 |
| 30 June 2023 | Citigroup | Downgrade | Sell | $22 → $21 |
| 1 May 2023 | Piper Sandler | Maintains | Neutral | $18 → $19 |
| 28 Apr 2023 | Stifel | Maintains | Hold | $24 → $25 |
| 18 Apr 2023 | B of A Securities | Downgrade | Underperform | $22 |
| 7 Feb 2023 | Citigroup | Maintains | Neutral | $21 → $26 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
CLB appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
- The AI build-out, every Wednesday: how AI stocks did, part by part.
CLB vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 22 Oct 2026, Core Laboratories, Inc. returned −26.2% against +15.6% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
CLB analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Core Laboratories, Inc. (CLB) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 19.5×
- Price / sales
- 0.9×
- Price / book
- 1.7×
- EV / EBITDA
- 10.7×
Cheaper than 39% of US stocks
Cheaper than 70% of US stocks
Cheaper than 48% of US stocks
Cheaper than 35% of US stocks
- Revenue growth (YoY)
- −4.3%
- Earnings growth (YoY)
- −44.0%
- Gross margin
- 15.6%
- Operating margin
- 7.4%
- Net margin
- 4.7%
Higher than 21% of US stocks
Higher than 12% of US stocks
Higher than 15% of US stocks
Higher than 59% of US stocks
Higher than 59% of US stocks
- Return on equity
- 9.0%
- Return on assets
- 4.4%
- Dividend yield
- 0.4%
Higher than 61% of US stocks
Higher than 73% of US stocks
Higher than 65% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Core Laboratories, Inc. (CLB) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Core Laboratories, Inc. has a market value of $464.8M and an enterprise value of $613.3M.
Revenue in the twelve months to 30 June 2026: $519.2M. The latest quarter shrank 4.3% year on year.
Net income over the same four quarters: $24.7M, a 4.8% net margin.
Diluted earnings per share, trailing twelve months: $0.55.
Free cash flow in the twelve months to 30 June 2026: $10.7M, after $17.3M of capital spending.
Core Laboratories, Inc. spent $14.4M on share buybacks and $1.9M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 19.5×; forward P/E: 14.7× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.39%, paying out 8% of earnings.
Core Laboratories, Inc. employs 3,300 people — $157K of revenue per employee.
Data provided by Twelve Data
CLB vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Core Laboratories, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about CLB stock
What is the CLB stock price forecast for 2026-2027?
The 3 Wall Street analysts covering Core Laboratories, Inc. have a median 12-month price target of $13, with estimates ranging from $11 to $21. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is CLB stock a buy right now?
Of the 3 analysts covering Core Laboratories, Inc., 2 rate it a Buy, 0 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Core Laboratories, Inc. 44 out of 100 across roughly 4,600 US stocks as at 22 Oct 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank CLB?
As at 22 Oct 2026, Core Laboratories, Inc. ranks 44 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (93 of 100).
Will CLB stock go up?
No one can know that. What the data says: the median 12-month target from 3 analysts implies +38.3% from the last close, and Ticker Nerd's factor model ranks Core Laboratories, Inc. 44 out of 100 as at 22 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the CLB stock forecast for 2030?
No analyst covering Core Laboratories, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CLB are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $11 to $21 over the next 12 months.
How has CLB stock performed over the past year?
Core Laboratories, Inc. returned -26.2% over the 12 months to 22 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Core Laboratories, Inc. do?
Core Laboratories Inc. is an oilfield services company that provides specialized reservoir description and production enhancement services and products to the oil and gas industry.
About Core Laboratories, Inc.
Core Laboratories Inc. is an oilfield services company that provides specialized reservoir description and production enhancement services and products to the oil and gas industry. Core Laboratories Inc. helps customers evaluate reservoir rock and fluid properties, improve well performance, and increase recovery from new and existing fields through laboratory analysis, field services, and proprietary technologies. Its business is organized into Reservoir Description and Production Enhancement, two complementary segments that support exploration, development, and production decisions. The company serves major, national, and independent oil companies across international markets, with operations in more than 50 countries. Core Laboratories Inc. also applies its technical expertise to subsurface evaluation work related to carbon capture and sequestration projects, reflecting its role in advanced energy and reservoir analysis.
CEO Mr. Lawrence V. Bruno · 3,300 employees · United States · https://www.corelab.com